• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Pregnancy Drug Linked To Cancer Spurs Legal Action As Effects Span Generations

April 11, 2025
in Medical Research
Reading Time: 2 mins read
A A
0
6
SHARES
13
VIEWS
Share on FacebookShare on Twitter


A once common pregnancy drug, prescribed to millions of women worldwide for decades before being discontinued, continues to wreak havoc across generations.

The drug, diethylstilbestrol, or DES, was a hormonal drug meant to prevent complications like miscarriage but has since been linked to a range of devastating effects, including cancers, premature births, miscarriages, and ectopic pregnancies.

A recent investigation in the U.K. has reignited calls for legal action, as hundreds of women, now known as DES daughters, reveal the lasting damage they have suffered after being exposed to the medication in the womb.

According to the National Cancer Institute in the U.S., DES daughters are about 40 times more likely to develop a rare vaginal cancer known as clear cell adenocarcinoma and are nearly twice as likely to develop breast cancer after the age of 40. Research also suggests an increased risk of pancreatic cancer and a higher likelihood of severe cervical cell changes.

DES was discontinued in the U.S. in 1971 after researchers noted shocking links to cancer while the drug continued to be prescribed to pregnant women in Europe until 1978.

In a recent ITV News investigation involving over 100 DES daughters whose mothers were prescribed the drug through the U.K.’s NHS, many shared the devastating impact it has had on their lives. They are now calling for greater awareness, routine screening, and compensation, warning that thousands more women may still be unaware of their exposure and the risks.

“It’s a pain that no woman should have to go through, it’s been barbaric at times. I’ve been in hospital for procedures or operations every year for the last 25 years,” said a 56-year-old DES daughter, Suzanne Massey from Liverpool who has undergone more than 30 medical procedures told the news outlet. Massey, who has been left unable to walk at times due to severe pain, is now preparing to take legal action.

Dr Ahmed Talaat, a gynecologist at the University Hospitals Plymouth NHS Trust who has treated 12 DES daughters emphasizes the importance of continuous monitoring and regular screenings to ensure early detection and prevention of potential health complications.

“The risk of cancer including cancer of vagina, or the cervix is nearly doubled in patients whose mothers received DES. That’s why they should be under close observation. Regular screening,” he said.

In the U.S., many DES daughters have sought legal recourse against the pharmaceutical companies that produced the drug, successfully securing compensation. They are also advised to undergo regular medical screenings, including gynecological exams and mammograms, to monitor for health issues linked to DES exposure.

In contrast, no similar legal victories have occurred in the U.K., primarily due to poor NHS record-keeping and the widespread, often casual, distribution of the drug. As a result, many women in the U.K. may never know if they were exposed to DES or be able to prove its impact on their health.


A once common pregnancy drug, prescribed to millions of women worldwide for decades before being discontinued, continues to wreak havoc across generations.

The drug, diethylstilbestrol, or DES, was a hormonal drug meant to prevent complications like miscarriage but has since been linked to a range of devastating effects, including cancers, premature births, miscarriages, and ectopic pregnancies.

A recent investigation in the U.K. has reignited calls for legal action, as hundreds of women, now known as DES daughters, reveal the lasting damage they have suffered after being exposed to the medication in the womb.

According to the National Cancer Institute in the U.S., DES daughters are about 40 times more likely to develop a rare vaginal cancer known as clear cell adenocarcinoma and are nearly twice as likely to develop breast cancer after the age of 40. Research also suggests an increased risk of pancreatic cancer and a higher likelihood of severe cervical cell changes.

DES was discontinued in the U.S. in 1971 after researchers noted shocking links to cancer while the drug continued to be prescribed to pregnant women in Europe until 1978.

In a recent ITV News investigation involving over 100 DES daughters whose mothers were prescribed the drug through the U.K.’s NHS, many shared the devastating impact it has had on their lives. They are now calling for greater awareness, routine screening, and compensation, warning that thousands more women may still be unaware of their exposure and the risks.

“It’s a pain that no woman should have to go through, it’s been barbaric at times. I’ve been in hospital for procedures or operations every year for the last 25 years,” said a 56-year-old DES daughter, Suzanne Massey from Liverpool who has undergone more than 30 medical procedures told the news outlet. Massey, who has been left unable to walk at times due to severe pain, is now preparing to take legal action.

Dr Ahmed Talaat, a gynecologist at the University Hospitals Plymouth NHS Trust who has treated 12 DES daughters emphasizes the importance of continuous monitoring and regular screenings to ensure early detection and prevention of potential health complications.

“The risk of cancer including cancer of vagina, or the cervix is nearly doubled in patients whose mothers received DES. That’s why they should be under close observation. Regular screening,” he said.

In the U.S., many DES daughters have sought legal recourse against the pharmaceutical companies that produced the drug, successfully securing compensation. They are also advised to undergo regular medical screenings, including gynecological exams and mammograms, to monitor for health issues linked to DES exposure.

In contrast, no similar legal victories have occurred in the U.K., primarily due to poor NHS record-keeping and the widespread, often casual, distribution of the drug. As a result, many women in the U.K. may never know if they were exposed to DES or be able to prove its impact on their health.

Tags: AwarenessCancer riskcancer risk after DES exposureDesDES daughtersdiscontinued drugeffects span generationsharm across generationshormonal druglegal actionnhspregnancy drugscreening
Previous Post

Spanish couple named as victims in fatal New York helicopter crash

Next Post

NASA offering $3 million to recycle 96 bags of poop left by Apollo astronauts 50 years back on the moon todayheadline

Related Posts

Many Are Not ‘Eligible for the Military’

May 23, 2025
2
Microsoft unveils AI agent orchestrator for cancer care coordination

Microsoft unveils AI agent orchestrator for cancer care coordination

May 23, 2025
6
Next Post
ET logo

NASA offering $3 million to recycle 96 bags of poop left by Apollo astronauts 50 years back on the moon todayheadline

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0

Impulse Space to launch SES satellites

May 23, 2025

Many Are Not ‘Eligible for the Military’

May 23, 2025
New Hampshire to pay $2.25M to mother of 5-year-old killed by father

New Hampshire to pay $2.25M to mother of 5-year-old killed by father

May 23, 2025
Trump and Harvard: What to know

Trump and Harvard: What to know

May 23, 2025

Recent News

Impulse Space to launch SES satellites

May 23, 2025
2

Many Are Not ‘Eligible for the Military’

May 23, 2025
2
New Hampshire to pay $2.25M to mother of 5-year-old killed by father

New Hampshire to pay $2.25M to mother of 5-year-old killed by father

May 23, 2025
3
Trump and Harvard: What to know

Trump and Harvard: What to know

May 23, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

Impulse Space to launch SES satellites

May 23, 2025

Many Are Not ‘Eligible for the Military’

May 23, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co